Medivar AB
3Patents
2Active
3Granted
38Portfolio score
Filing activity: Feb 28, 1978 → Aug 3, 2011 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8148399B2 | Macrocyclic inhibitors of hepatitis C virus | Emerging Cross-Sectional Technologies | 20 | Active |
| US8153800B2 | Macrocyclic inhibitors of hepatitis C virus | Emerging Cross-Sectional Technologies | 7 | Active |
| US4234603A | Skin-treating composition and vehicle for skin-treating agents | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.